Revvity, headquartered in Waltham, Massachusetts, offers health science solutions across Life Sciences and Diagnostics, employing 11,500 staff. Its products support workflows from discovery to diagnosis in various medical fields.
Joel S Goldberg sold 15,170 shares of RVTY on 30 January at $127.77 per share, worth a total of $1.9M. They now own 48,070 RVTY shares, or a 31% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
